共有 50 笔近期内部人交易记录记录，涉及 Armata Pharmaceuticals, Inc. (ARMP), 包括 37 笔买入 和 8 笔卖出. 内部人买入总额为 $14.19M 内部人卖出总额为 $559.62K.
近期活跃的重要内部人包括 Birx Deborah, Kyme Pierre, Patti Joseph M. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — ARMP
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-14 |
Birx Deborah |
Chief Executive Officer |
RSU 预扣税 |
4,919 |
$10.54 |
$51.85K |
212,458 |
| 2026-03-14 |
Kyme Pierre |
Chief Business Officer |
RSU 预扣税 |
1,030 |
$10.54 |
$10.86K |
9,461 |
| 2026-03-09 |
Patti Joseph M |
Director |
限制性股票授予 (RSU) |
25,640 |
$11.61 |
$297.68K |
25,640 |
| 2026-03-09 |
Haimovitz Jules |
Director |
限制性股票授予 (RSU) |
25,640 |
$11.61 |
$297.68K |
25,640 |
| 2026-03-09 |
Odysseas Kostas D |
Director |
限制性股票授予 (RSU) |
25,640 |
$11.61 |
$297.68K |
25,640 |
| 2026-03-09 |
Schlesinger Sarah J. |
Director |
限制性股票授予 (RSU) |
25,640 |
$11.61 |
$297.68K |
25,640 |
| 2026-03-09 |
Kramer Robin |
Director |
限制性股票授予 (RSU) |
25,640 |
$11.61 |
$297.68K |
25,640 |
| 2026-03-09 |
Peterson Todd C. |
Director |
限制性股票授予 (RSU) |
25,640 |
$11.61 |
$297.68K |
25,640 |
| 2026-03-09 |
Birx Deborah |
Chief Executive Officer |
限制性股票授予 (RSU) |
421,226 |
$11.61 |
$4.89M |
421,226 |
| 2026-03-09 |
Kyme Pierre |
Chief Business Officer |
限制性股票授予 (RSU) |
183,142 |
$11.61 |
$2.13M |
183,142 |
| 2026-03-09 |
House David Duane |
SVP, Finance, and Pfo |
限制性股票授予 (RSU) |
109,885 |
$11.61 |
$1.28M |
109,885 |
| 2025-07-10 |
Birx Deborah |
Chief Executive Officer |
RSU 预扣税 |
13,637 |
$2.27 |
$30.96K |
217,377 |
| 2025-03-14 |
Birx Deborah |
Chief Executive Officer |
RSU 预扣税 |
6,061 |
$1.95 |
$11.82K |
231,014 |
| 2025-03-14 |
Kyme Pierre |
Chief Business Officer |
RSU 预扣税 |
1,027 |
$1.95 |
$2K |
10,491 |
| 2025-02-05 |
Patti Joseph M |
Director |
限制性股票授予 (RSU) |
54,343 |
$2.04 |
$110.86K |
54,343 |
| 2025-02-05 |
Haimovitz Jules |
Director |
限制性股票授予 (RSU) |
54,343 |
$2.04 |
$110.86K |
54,343 |
| 2025-02-05 |
Odysseas Kostas D |
Director |
限制性股票授予 (RSU) |
54,343 |
$2.04 |
$110.86K |
54,343 |
| 2025-02-05 |
Schlesinger Sarah J. |
Director |
限制性股票授予 (RSU) |
54,343 |
$2.04 |
$110.86K |
54,343 |
| 2025-02-05 |
Kramer Robin |
Director |
限制性股票授予 (RSU) |
54,343 |
$2.04 |
$110.86K |
54,343 |
| 2025-02-05 |
Peterson Todd C. |
Director |
限制性股票授予 (RSU) |
54,343 |
$2.04 |
$110.86K |
54,343 |
| 2025-02-05 |
Birx Deborah |
Chief Executive Officer |
限制性股票授予 (RSU) |
240,000 |
$2.04 |
$489.6K |
240,000 |
| 2025-02-05 |
Kyme Pierre |
Chief Business Officer |
限制性股票授予 (RSU) |
100,000 |
$2.04 |
$204K |
100,000 |
| 2025-02-05 |
House David Duane |
SVP, Finance, and Pfo |
限制性股票授予 (RSU) |
25,000 |
$2.04 |
$51K |
25,000 |
| 2024-10-02 |
House David Duane |
SVP, Finance, and Pfo |
限制性股票授予 (RSU) |
75,000 |
$2.32 |
$174K |
75,000 |
| 2024-08-16 |
House David Duane |
Officer |
未知 |
- |
- |
- |
- |
| 2024-07-10 |
Birx Deborah |
Chief Executive Officer |
RSU 预扣税 |
22,925 |
$2.68 |
$61.44K |
237,075 |
| 2024-06-19 |
Kyme Pierre |
Chief Business Officer |
未知 |
50,000 |
$5.11 |
$255.5K |
- |
| 2024-06-19 |
Kyme Pierre |
Chief Business Officer |
处置 |
40,000 |
$3.38 |
$135.2K |
- |
| 2024-03-14 |
Patti Joseph M |
Director |
限制性股票授予 (RSU) |
39,666 |
$3.38 |
$134.07K |
39,666 |
| 2024-03-14 |
Haimovitz Jules |
Director |
限制性股票授予 (RSU) |
39,666 |
$3.38 |
$134.07K |
39,666 |
| 2024-03-14 |
Odysseas Kostas D |
Director |
限制性股票授予 (RSU) |
39,666 |
$3.38 |
$134.07K |
39,666 |
| 2024-03-14 |
Schlesinger Sarah J. |
Director |
限制性股票授予 (RSU) |
39,666 |
$3.38 |
$134.07K |
39,666 |
| 2024-03-14 |
Kramer Robin |
Director |
限制性股票授予 (RSU) |
39,666 |
$3.38 |
$134.07K |
39,666 |
| 2024-03-14 |
Peterson Todd C. |
Director |
限制性股票授予 (RSU) |
39,666 |
$3.38 |
$134.07K |
39,666 |
| 2024-03-14 |
Birx Deborah |
Chief Executive Officer |
限制性股票授予 (RSU) |
240,000 |
$3.38 |
$811.2K |
240,000 |
| 2024-03-14 |
Rychlik Richard |
Corporate Controller and Pfo |
限制性股票授予 (RSU) |
10,000 |
- |
- |
10,000 |
| 2023-12-21 |
Patti Joseph M |
Director |
限制性股票授予 (RSU) |
10,461 |
$2.39 |
$25K |
10,461 |
| 2023-12-21 |
Haimovitz Jules |
Director |
限制性股票授予 (RSU) |
10,461 |
$2.39 |
$25K |
10,461 |
| 2023-12-21 |
Odysseas Kostas D |
Director |
限制性股票授予 (RSU) |
10,461 |
$2.39 |
$25K |
10,461 |
| 2023-12-21 |
Schlesinger Sarah J. |
Director |
限制性股票授予 (RSU) |
10,461 |
$2.39 |
$25K |
10,461 |
| 2023-12-21 |
Kramer Robin |
Director |
限制性股票授予 (RSU) |
10,461 |
$2.39 |
$25K |
10,461 |
| 2023-12-21 |
Peterson Todd C. |
Director |
限制性股票授予 (RSU) |
10,461 |
$2.39 |
$25K |
10,461 |
| 2023-12-21 |
Birx Deborah |
Chief Executive Officer |
限制性股票授予 (RSU) |
200,000 |
$2.39 |
$478K |
200,000 |
| 2023-12-21 |
Rychlik Richard |
Corporate Controller and Pfo |
限制性股票授予 (RSU) |
50,000 |
$2.39 |
$119.5K |
50,000 |
| 2023-09-15 |
Rychlik Richard |
Officer |
未知 |
- |
- |
- |
- |
| 2023-07-10 |
Birx Deborah |
Chief Executive Officer |
未知 |
- |
- |
- |
- |
| 2023-05-02 |
Averill Julianne |
Officer |
未知 |
- |
- |
- |
- |
| 2023-01-10 |
Innoviva, Inc. |
Director |
知情买入 |
- |
$30,000,000.00 |
- |
- |
| 2022-07-01 |
Butler Erin |
Vice President,finance & Admin |
处置 |
50,000 |
$5.11 |
$255.5K |
- |
| 2022-04-13 |
Patti Joseph M |
Director |
限制性股票授予 (RSU) |
33,000 |
$5.11 |
$168.63K |
33,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
